Loading...
Pramipexole use and the risk of pneumonia
BACKGROUND: Patients with Parkinson's disease have an elevated risk of pneumonia and randomized trials suggest that this risk may be increased with the dopamine agonist pramipexole. It is uncertain whether pramipexole or other dopamine agonists increase the risk of pneumonia. METHODS: We used t...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3522019/ https://ncbi.nlm.nih.gov/pubmed/23020246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-12-113 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|